Supplemental material
Journal of Asthma
Volume 59, 2022 - Issue 8
Open access
2,231
Views
1
CrossRef citations to date
0
Altmetric
Pharmacotherapy
Once-daily, single-inhaler indacaterol/mometasone versus twice-daily salmeterol/fluticasone in Asian patients with inadequately controlled asthma: post hoc pooled analysis from PALLADIUM and IRIDIUM studies
Yasuhiro Gona Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, JapanCorrespondence[email protected]
View further author information
, MD, PhD, View further author information
Tsuyoshi Ishiib Novartis Pharma K.K, Tokyo, Japan
https://orcid.org/0000-0001-7235-9221View further author information
, PhD, MBADavid Lawrencec Novartis Pharma AG, Basel, SwitzerlandView further author information
, PhD, Ivan Nikolaevc Novartis Pharma AG, Basel, SwitzerlandView further author information
, MD, Dong Wangb Novartis Pharma K.K, Tokyo, JapanView further author information
, PhD, Kazuya Sumib Novartis Pharma K.K, Tokyo, JapanView further author information
, MPHARM & Yoichi Nakamurad Department of Allergology, Medical Center for Allergy and Immune Diseases, Yokohama City Minato Red Cross Hospital, Yokohama, JapanView further author information
, MD show all
Pages 1627-1637
|
Received 13 May 2021, Accepted 26 Jul 2021, Published online: 24 Aug 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.